Home ›› 27 Oct 2021 ›› Stock
The ACME Laboratories Limited has recommended a 25 per cent cash dividend to its shareholders for the year ending on June 30.
The dividend recommendation came yesterday at a meeting of the pharmaceutical company’s board of directors.
The dividend will get final approval during the annual general meeting (AGM) scheduled to be held on December 26. The record date is set for November 18.
The publicly traded company has reported consolidated earnings per share (EPS) of Tk 7.42 and consolidated net asset (NAV) per share of Tk 95.04 for the year.
There will be no price limit on the trading of the shares of the company today following its corporate declaration.
Each share of the company, which was listed on the Dhaka Stock Exchange (DSE) in 2016 under the book building method, closed at Tk 91.30 at the Dhaka bourse yesterday.
Currently, the ACME Laboratories has a paid-up capital of Tk 211 crore.
It produces more than 500 products in different dosage forms covering broader therapeutic categories.
